Z67.A3

Clinical Causes: Genetic inheritance: The Duffy blood group phenotypes are inherited traits determined by specific genes inherited from biological parents. Duffy antigen expression: Variations in the gene coding for the Duffy antigens result in different phenotypes, including Fy(a-b+). Population-specific genetics: The Fy(a-b+) phenotype is more common in certain populations, notably among individuals of African descent, affecting disease susceptibility and blood transfusion compatibility.

Key Symptoms: Typically, there are no direct symptoms associated with the Duffy B positive phenotype, as it is a genetic blood type trait rather than a disease. In some cases, individuals might experience complications related to blood transfusions if blood types are not properly matched, leading to transfusion reactions. Potential implications in susceptibility to certain infections, such as malaria caused by Plasmodium vivax, where Duffy antigens serve as a receptor for the parasite. Possible influence on immune response due to blood group antigen differences.

Diagnosis Path: Diagnosis of the Duffy B positive phenotype involves blood testing that identifies the presence of specific Duffy antigens on red blood cells. Laboratory techniques, such as hemagglutination assays or molecular testing, can determine the exact blood group profile, confirming the Fy(a-b+) phenotype. Blood typing laboratories use specific antibodies to detect Duffy antigens as part of routine blood group determination.

Treatment Protocols: Since the Fy(a-b+) phenotype is a genetic trait, there is no treatment needed specifically for this blood group. The primary concern in medical practice is ensuring appropriate blood matching during transfusions to prevent hemolytic reactions. Blood banks maintain records of blood group phenotypes to facilitate safe transfusions and manage any related complications effectively.